Covered recipient · General Payments record
SASAN MOGHIMI ARAGHI
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2020–2024
$5,797.09
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,500.00 | 1 |
| Food and Beverage | $1,379.55 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $1,720.82 | 5 |
| Alcon Laboratories Inc | $540.31 | 6 |
| ABBVIE INC. | $466.35 | 4 |
| Sight Sciences, Inc. | $122.88 | 2 |
| Amgen Inc. | $29.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $111.39 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050472 | CMS |
| ABBVIE INC. | $111.79 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050474 | CMS |
| ABBVIE INC. | $119.30 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050476 | CMS |
| ABBVIE INC. | $123.87 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105050478 | CMS |
| Alcon Vision LLC | $142.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110704532 | CMS |
| Alcon Vision LLC | $124.12 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700128 | CMS |
| Alcon Vision LLC | $132.43 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700130 | CMS |
| Alcon Vision LLC | $68.11 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700126 | CMS |
| Alcon Vision LLC | $20.70 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700122 | CMS |
| Alcon Vision LLC | $52.62 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110700124 | CMS |
| Amgen Inc. | $29.19 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115938412 | CMS |
| Glaukos Corporation | $34.26 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151986322 | CMS |
| Glaukos Corporation | $1,500.00 | 04/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1151973127 | CMS |
| Glaukos Corporation | $136.62 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151976006 | CMS |
| Glaukos Corporation | $26.45 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151976004 | CMS |
| Glaukos Corporation | $23.49 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982722 | CMS |
| Sight Sciences, Inc. | $100.89 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151930689 | CMS |
| Sight Sciences, Inc. | $21.99 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151930687 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.